.
MergerLinks Header Logo

New Deal

New Deal

Announced

Completed

Bridgepoint completed the acquisition of Laboratoires Vivacy for $940m.

Financials

Edit Data
Transaction Value£773m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Bridgepoint Group

bidder

Bridgepoint Group

Laboratoires Vivacy

target

Laboratoires Vivacy

Ta Associates

vendor

Ta Associates

Sources

Edit

Tags

Edit

Private Equity

Completed

Medical Equipment

Friendly

France

Single Bidder

Majority

medical devices

Cross Border

Acquisition

Private

Synopsis

Edit

Bridgepoint, a private investment company, completed the acquisition of Laboratoires Vivacy, a medical devices provider, for $940m.

Service Providers

Dealmakers (6)

William Jackson

William Jackson

Managing Partner at BRIDGEPOINT GROUP
Deal Bio
Total Deals
18/
Total Value
£5,657M
Laurent Bensaid

Laurent Bensaid

Partner at King & Spalding
Deal Bio
Total Deals
21/
Total Value
£5,482M
Michel Cheron

Michel Cheron

CEO at LABORATOIRES VIVACY
Deal Bio
Total Deals
1/
Total Value
£774M
Laurent Baril

Laurent Baril

Managing Director at Rothschild & Co
Deal Bio
Total Deals
35/
Total Value
£27,273M
Robert Rozemulder

Robert Rozemulder

Managing Director at Rothschild & Co
Deal Bio
Total Deals
29/
Total Value
£18,298M
Gaetan Gianasso

Gaetan Gianasso

Partner at Latham & Watkins
Deal Bio
Total Deals
50/
Total Value
£15,802M

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required
Register nowSign up with LinkedIn

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US